HomeCompareDAIUF vs JNJ

DAIUF vs JNJ: Dividend Comparison 2026

DAIUF yields 1.39% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DAIUF wins by $14.79M in total portfolio value
10 years
DAIUF
DAIUF
● Live price
1.39%
Share price
$33.05
Annual div
$0.46
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$14.82M
Annual income
$13,027,464.47
Full DAIUF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — DAIUF vs JNJ

📍 DAIUF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDAIUFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DAIUF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
DAIUF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DAIUF
Annual income on $10K today (after 15% tax)
$118.39/yr
After 10yr DRIP, annual income (after tax)
$11,073,344.80/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, DAIUF beats the other by $11,069,358.81/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DAIUF + JNJ for your $10,000?

DAIUF: 50%JNJ: 50%
100% JNJ50/50100% DAIUF
Portfolio after 10yr
$7.43M
Annual income
$6,516,076.94/yr
Blended yield
87.73%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

DAIUF
No analyst data
Altman Z
6.4
Piotroski
6/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DAIUF buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDAIUFJNJ
Forward yield1.39%2.13%
Annual dividend / share$0.46$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%28%
Portfolio after 10y$14.82M$30.3K
Annual income after 10y$13,027,464.47$4,689.40
Total dividends collected$14.66M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: DAIUF vs JNJ ($10,000, DRIP)

YearDAIUF PortfolioDAIUF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,979$278.57$10,592$272.30+$387.00DAIUF
2$12,319$571.64$11,289$357.73+$1.0KDAIUF
3$14,380$1,198.91$12,123$472.89+$2.3KDAIUF
4$18,002$2,615.91$13,141$629.86+$4.9KDAIUF
5$25,384$6,121.30$14,408$846.81+$11.0KDAIUF
6$43,294$16,133.07$16,021$1,151.60+$27.3KDAIUF
7$97,756$51,431.73$18,122$1,588.22+$79.6KDAIUF
8$321,667$217,067.78$20,930$2,228.20+$300.7KDAIUF
9$1,679,253$1,335,069.44$24,792$3,191.91+$1.65MDAIUF
10$14,824,265$13,027,464.47$30,274$4,689.40+$14.79MDAIUF

DAIUF vs JNJ: Complete Analysis 2026

DAIUFStock

Daifuku Co., Ltd. provides consulting, engineering, design, manufacture, installation, and after-sales services for logistics systems and material handling equipment in Japan and internationally. The company offers automated warehousing, various storage and transport, and sorting and picking systems to distributors, including e-commerce, retail, wholesale, transportation, and warehousing customers, as well as to food, pharmaceuticals, and chemicals manufactures; and cleanroom transport and storage systems used in manufacturing semiconductors and flat panel displays for smartphones and tablet computers. It also provides systems for automobile production processes; and solutions for airports comprising baggage handling systems, automated baggage check-in systems, baggage screening systems, and software and controls. In addition, the company offers car wash machines to filling stations and automobile dealers; and high-end industrial personal computers, controllers used in medical devices, computers built in digital signage, and measuring/control systems for solar facilities, as well as IT systems and wireless power supply solutions. The company was formerly known as Daifuku Machinery Works Co., Ltd. Daifuku Co., Ltd. was founded in 1937 and is headquartered in Osaka, Japan.

Full DAIUF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this DAIUF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DAIUF vs SCHDDAIUF vs JEPIDAIUF vs ODAIUF vs KODAIUF vs MAINDAIUF vs ABBVDAIUF vs MRKDAIUF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.